FIGURE 6 Changes in content and bioaccessibility of DHA, EPA, and Astaxanthin during In Vitro digestion. DHA content (A), EPA content (B), and astaxanthin content (C) of KO emulsions prepared by HPH / MF after exposure to different regions of a simulated GIT. Bioaccessibility (D) of astaxanthin, DHA, and EPA in KO emulsions prepared by HPH / MF as they pass through different regions of a simulated GIT